G-protein coupled receptors (GPCRs) are targets for 1/3 of the drugs available on the market making research on this class of proteins a very hot topic in the field of drug discovery. γ-amino butyric acid (GABA) and glutamate are respectively the main inhibitory and the main excitatory neurotransmitters in the mammalian central nervous system (CNS). The GABAB receptor (GABAB-R) and the metabotropic glutamate receptors 1-8 (mGlu1-8-Rs) belong to family C GPCRs and are functional dimers. They are potential drugs targets for the treatments of CNS disorders among others. GABAB-R is also involved in drug and alcohol addictions. The actual therapeutic treatments for CNS diseases come with serious side-effects due to off-target binding. Allosteric...
G protein-coupled receptors (GPCRs) are integral membrane proteins responsible for signal transducti...
γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system, an...
International audienceThe recent discovery of positive allosteric modulators (PAMs) for G-protein-co...
Drug discovery programs increasingly are focusing on allosteric modulators as ameans tomodify the ac...
-aminobutyric acid (GABA) is the chief inhibitory neurotransmitter of the central nervous system (CN...
The metabotropic glutamate 5 (mGlu5) receptor is a class C G protein-coupled receptor (GPCR) that is...
Since its cloning, the GABAB receptor has progressively become a target for potential drugs to be us...
Since its cloning, the GABAB receptor has progressively become a target for potential drugs to be us...
Since its cloning, the GABAB receptor has progressively become a target for potential drugs to be us...
International audienceRecently determined structures of class C G protein-coupled receptors (GPCRs) ...
G protein-coupled receptors represent the largest family of druggable targets in the human genome, w...
AbstractThe discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a pro...
The gamma-amino-butyric-acid (GABA) is the main inhibitory neurotransmitter in the central nervous s...
γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system, an...
Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed the location ...
G protein-coupled receptors (GPCRs) are integral membrane proteins responsible for signal transducti...
γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system, an...
International audienceThe recent discovery of positive allosteric modulators (PAMs) for G-protein-co...
Drug discovery programs increasingly are focusing on allosteric modulators as ameans tomodify the ac...
-aminobutyric acid (GABA) is the chief inhibitory neurotransmitter of the central nervous system (CN...
The metabotropic glutamate 5 (mGlu5) receptor is a class C G protein-coupled receptor (GPCR) that is...
Since its cloning, the GABAB receptor has progressively become a target for potential drugs to be us...
Since its cloning, the GABAB receptor has progressively become a target for potential drugs to be us...
Since its cloning, the GABAB receptor has progressively become a target for potential drugs to be us...
International audienceRecently determined structures of class C G protein-coupled receptors (GPCRs) ...
G protein-coupled receptors represent the largest family of druggable targets in the human genome, w...
AbstractThe discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a pro...
The gamma-amino-butyric-acid (GABA) is the main inhibitory neurotransmitter in the central nervous s...
γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system, an...
Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed the location ...
G protein-coupled receptors (GPCRs) are integral membrane proteins responsible for signal transducti...
γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the central nervous system, an...
International audienceThe recent discovery of positive allosteric modulators (PAMs) for G-protein-co...